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ABSTRACT Vitamin K-dependent carboxylase catalyzes
the modification of specific glutamic acids to y-carboxyglu-
tamic acid in several blood-coagulation proteins. This modifi-
cation is required for the blood-clotting activity of these
proteins and has thus been the subject of intense investigation.
We have now identified the bovine vitamin K-dependent car-
boxylase and purified it to near homogeneity by an affinity
procedure that uses the 59-amino acid peptide FIXQ/S (resi-
dues -18 to 41 of factor IX with mutations Arg -- Gin at
residue -4 and Arg -+ Ser at residue -1). The carboxylase as
purified has a molecular weight of 94,000. It is also the major
protein that can be cross-linked to iodinated FIXQ/S and is the
only protein whose cross-linking is prevented by a synthetic
factor IX propeptide. The degree of purification is about
7000-fold with reference to ammonium sulfate-fractionated
microsomal protein from liver.
A number of blood coagulation proteins require a posttrans-
lational vitamin K-dependent modification for biological ac-
tivity. Stenflo et al. (1), Nelsestuen et al. (2), and Magnusson
et al. (3) have reported that prothrombin, the prototype of
these vitamin K-dependent proteins, contained the modified
amino acid y-carboxyglutamic acid (Gla). Prothrombin from
animals treated with the vitamin K antagonist warfarin lacked
this Gla modification. It was inferred from these observations
that the blood-clotting activity of the vitamin K-dependent
proteins required y-carboxylation of specific glutamic acid
residues. Shortly thereafter, Esmon et al. (4) demonstrated
an enzyme activity, vitamin K-dependent carboxylase (here-
after called carboxylase), capable of making this Gla modi-
fication.
After cDNA sequences were obtained for several of the
vitamin K-dependent proteins, Pan and Price (5) compared
the deduced amino acid sequences and suggested that the
propeptide consensus sequence preceding the amino termi-
nus ofthe vitamin K-dependent protein was a recognition site
for the carboxylase. This suggestion was confirmed by Kno-
bloch and Suttie (6), who demonstrated the importance ofthe
propeptide in carboxylation by showing that the synthetic
propeptide sequence of human factor X stimulated the ac-
tivity of the carboxylase for a small substrate (Boc-Glu-Glu-
Leu-OMe) in vitro. Jorgensen et al. (7) extended this obser-
vation by showing that factor IX with its propeptide deleted
was not carboxylated.
In spite of its importance, the carboxylase has not been
previously purified. Purification of 400-fold was reported by
Girardot (8). Comparison of Girardot's results to later puri-
fications is complicated because, in our hands, ammonium
sulfate and the propeptide stimulate the incorporation ofCO2
into the synthetic peptide substrate FLEEL by 13-fold. Ifone
corrects for the lack of ammonium sulfate and propeptide in
Girardot's assay mix, then he achieved a specific activity of
1.1 x 107 cpm per mg per hr. Soute et al. (9) demonstrated
that an immobilized factor X antibody would bind the car-
boxylase, presumably through a factor X precursor-
carboxylase complex, and that the bound carboxylase re-
tained its activity for the synthetic peptide substrate FLEEL.
Harbeck et al. (10) extended this method by eluting the
carboxylase from a prothrombin antibody column with a
synthetic propeptide achieving a 500-fold purification and a
final specific activity of6.6 x 106 cpm per mg per hr. Hubbard
et al. (11) reported the purification of the carboxylase to
homogeneity using a synthetic propeptide sequence as an
affinity ligand. However, the reported final specific activity
of 1.3 x 107 cpm per mg per hr was still not significantly
different than that reported by Girardot (8). Numerous stud-
ies with the crude carboxylase have yielded important infor-
mation about its properties and mode of action (12). It is
clear, however, that for detailed mechanistic studies and
physical characterization of the enzyme, purification is nec-
essary.
We recently reported the production in Escherichia coli of
four 59-residue peptides containing the propeptide and Gla
domain of human factor IX (13). We report here that one of
these peptides, FIXQ/S (residues -18 to 41 offactor IX with
mutations Arg - Glu at residue -4 and Arg -+ Ser at residue
-1), is an excellent affinity ligand for purification of the
carboxylase. A 7000-fold purification of the carboxylase to
80-90%o apparent purity and final specific activity ofabout 2.4
x 109 cpm per mg per hr was obtained. The apparent
molecular weight was 94,000 by reducing SDS/PAGE anal-
ysis.
MATERIALS AND METHODS
All chemicals are reagent grade. 3,3'-Dithiobis(sulfosuccin-
imidylpropionate) was purchased from Pierce. Aprotinin and
pepstatin A were purchased from Boehringer Mannheim.
Leupeptin, phenylmethylsulfonyl fluoride, and 3-[(3-cholami-
dopropyl)dimethylammonio]-1-propanesulfonate (CHAPS)
were obtained from Sigma. The peptide FLEEL and the
protease inhibitors FFRCK and FPRCK were from Bachem.
Peptide proFIXl9, AVFLDHENANKILNRPKRY, was
synthesized by Frank Church (University of North Carolina
at Chapel Hill). NaH14CO3, specific activity 50.0 mCi/mmol
(1 Ci = 37 GBq), was from NEN and Aqua Mephyton was
from Merck Sharp & Dohme. Protease inhibitor mixture
(PIC) was freshly prepared as a 10x PIC stock containing 20
mM dithiothreitol, 20 mM EDTA, FFRCK (1.25 ,ug/ml),
FPRCK (1.25 gg/ml), leupeptin (5 pug/ml), pepstatin A (7
,ug/ml), phenylmethylsulfonyl fluoride (340 ,Ag/ml), and
aprotinin (20.ug/ml).
Preparation of Affinity Column. Peptide FIXQ/S (13) with
two mutations in the propeptide was chosen for the affinity
Abbreviations: FIXQ/S, residues -18 to 41 of factor IX with
mutations Arg -- Gln at residue -4 and Arg -- Ser at residue -1;
Gla, -carboxyglutamic acid; CHAPS, 3-[(3-cholamidopropyl)di-
methylammonio]-1-propanesulfonate.
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ligand because its affinity for the carboxylase is not changed
and because it has fewer trypsin cleavage sites than our other
peptides and is, therefore, less likely to be degraded by
proteases in the crude extracts used for purification. Peptide
FIXQ/S was prepared according to Wu et al (13). FIXQ/S
(100 mg) was coupled to 25 ml of Affi-Gel 10 (Bio-Rad)
according to the manufacturer. The reaction was done at pH
4.8, which is one unit below the theoretical pI of FIXQ/S.
The final concentration of the covalently bound FIXQ/S on
Affi-Gel 10 was measured as 442 /uM and the coupled ligand
is referred to as Affi-FIXQ/S.
Affinity Purification of Carboxylase. Preparation of mi-
crosomes from bovine liver, solubilization ofmicrosomes, and
ammonium sulfate fractionation were as described by Girardot
(8). Protein concentration was measured with the Bio-Rad
protein assay kit (14). Alternatively, protein concentration and
relative purity were determined by scanning of SDS/PAGE
gels (15) stained with silver (16) or Coomassie blue. In all
cases, reference curves were prepared with IgG as a standard.
Ammonium sulfate-fractionated microsomal protein (7-8 g)
was resuspended in buffer A [25 mM Mops, pH 7.0/500 mM
NaCl/20%o (vol/vol) glycerol/0.1% phosphatidylcholine/lx
PIC]/0.1% CHAPS to a total volume of 150 ml. In all purifi-
cation experiments, except that depicted in Fig. 1, lane 3, the
suspension was sonicated with a standard ultrasonic probe
(sonicator model W-220F, Heat Systems/Ultrasonics) at scale
9 for 100 2-sec pulses in an ice bath. The sonicated material
was loaded on a 25-ml Affi-FIXQ/S column equilibrated with
150 ml of 0.1% CHAPS/buffer A at 4°C at a flow rate of 10
ml/hr. The loaded column was washed with 100-200 ml of
0.1% CHAPS/buffer A. The carboxylase was eluted from the
Affi-FIXQ/S column by one of the following methods.
Elution l. Propeptide (150 ,uM) in buffer A/0.1% CHAPS
was used to elute the carboxylase. The column was filled with
eluant and incubated overnight before collecting the eluate.
The propeptide eluate was concentrated with Centricon-30
(Amicon); the filtrate could be reused for elution. Significant
amounts ofcarboxylase activity were continuously eluted for
a week.
Elution II. A flow rate of 10 ml/hr was used for all
chromatography steps. An extensive wash was carried out by
two sequential steps: a 100-ml 0.05-0.85% Triton X-100
gradient in buffer B (25mM Mops, pH 7.0/50mM NaCl/20%6
glycerol/1 x PIC) containing 0.2% phosphatidylcholine was
followed by a 100-ml 0.1-1% CHAPS gradient in buffer B
containing 0.1% phosphatidylcholine. Elution was accom-
plished by using 100 ml of a double gradient containing
0.1-1% CHAPS and 0-2 ,uM proFIX19 in buffer A and
continued with another 100 ml containing 1% CHAPS and 2
,uM proFIX19 in buffer A.
CM-Sepharose Chromatography. Desalted concentrated
carboxylase (total activity of 2.2 x 107 cpm/30 min) eluted by
method I was prepared in buffer C (25 mM Mops, pH 7.0/100
mM NaCl/20% glycerol/1 x PIC) containing 1% Triton X-100
and 0.7% phosphatidylcholine to a total volume of 3.85 ml.
This carboxylase preparation was then sonicated in a bath
sonicator for twenty-four 5-sec pulses and batch-adsorbed to
5.8 ml ofCM-Sepharose. The CM-Sepharose was packed into
a column, washed, and eluted with a 10-ml 100-450mM NaCl
gradient in buffer C containing 0.05% Triton X-100 and 0.2%
phosphatidylcholine.
Cross-Linking Reaction. The cross-linking was accom-
plished with 3,3'-dithiobis(sulfosuccinimidyl propionate) as
described by Jung and Moroi (17). For competition experi-
ments, 100-fold excess of proFIX19 was included.
Carboxylase Assay. The assay was done for 30 min as
described (13) in 25 mM Mops, pH 7.0/500 mM NaCl/0.16%
CHAPS/0.16% phosphatidylcholine. FLEEL at 3.6 mM and
5 gCi of NaHl4CO3 were the substrates; 0.8 M ammonium
sulfate and 16 jLM proFIXl9 were included as activators.
RESULTS
Identification of the Carboxylase. Fig. 1 displays a reducing
SDS/PAGE analysis of our initial Affi-FIXQ/S purification
of carboxylase. There is little difference between the protein
pattern of the starting material and the flow-through (lanes 1
and 2, respectively). The sample in lane 3 represents protein
eluted with 150 ,uM proFIXl9. There is some enhancement of
a protein band at Mr 94,000 but the purification achieved is
only 60-fold. We reasoned that the poor purification might be
the result of large micelles that contained at least one
carboxylase molecule as well as other integral membrane
proteins. The carboxylase molecule would allow binding to
the affinity matrix but the other proteins would be coeluted
with the carboxylase. We tried to apply the standard solution
to this problem, which is to increase the detergent concen-
tration until one protein per micelle is achieved. However,
the carboxylase would not bind to Affi-FIXQ/S in the
presence of a high concentration of a number of detergents.
Therefore, we sought to reduce the micelle size by sonicating
the starting material. As shown in Fig. 1, lane 4, the relative
intensity of the Mr 94,000 band in the proFIX19 eluate is
much more prominent after sonication. Furthermore, the
amount of carboxylase bound to Affi-FIXQ/S increased from
15 to 30% and the purification increased to 500-fold.
To evaluate the binding specificity ofFIXQ/S and attain an
independent estimate of the molecular weight of the carbox-
ylase, we cross-linked 1251-labeled FIXQ/S to 60-fold affin-
ity-purified material (Fig. 1, lane 3). The autoradiogram in
Fig. 2, lane 2, shows one major band, slightly larger than Mr
97,000 that represents the complex ofthe cross-linked protein
and 1251-labeled FIXQ/S. This major band was eliminated
when the same experiment was run in the presence of excess
nonradioactive proFIX19 (Fig. 2, lane 1). The minor bands in
lane 2 were unaffected by competition (lane 1). By subtract-
ing the molecular weight of FIXQ/S (Mr 7000) from the
estimated size of the cross-linked complex, we estimate that
the size of the protein to which the FIXQ/S peptide binds is
approximately Mr 94,000. This agrees with the size of the
band enriched in each of the early purifications (Fig. 1),
indicating that the Mr 94,000 protein (lanes 3 and 4) is the
enzyme carboxylase and that the interaction between the
peptide FIXQ/S and carboxylase is very specific.





FIG. 1. Reducing SDS/PAGE analysis (silver-stained 10o gel) of
Affi-FIXQ/S-purified carboxylase preparations demonstrate the ef-
fect of sonication. The cpm reflect the carboxylase activity in each
lane. Lane 1 is the sonicated loading material (380 cpm/30 min); lane
2 is the sonicated flow-through (265 cpm/30 min); lane 3 is unsoni-
cated elution I carboxylase preparation (23,500 cpm/30 min); lane 4
is sonicated elution I carboxylase preparation (5000 cpm/30 min).
Molecular weights (x10-3) are shown to the left.
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FIG. 2. Autoradiogram of cross-linking between 1251-labeled
FIXQ/S and protein from the partially purified carboxylase prepa-
ration shown in Fig. 1, lane 3. Proteins were separated by nonre-
ducing SDS/PAGE on a 10%o gel. Lane 1 is proFIX19 competition of
cross-linking; lane 2 is cross-linking in absence of proFIX19. Mo-
lecular weights (x 10-3) are shown to the left.
Results shown in Fig. 3 indicate that further purification
can be achieved by chromatography of the 500-fold affinity-
purified material on CM-Sepharose. Resolubilization, soni-
cation, and batch adsorption on CM-Sepharose followed by
elution with a salt gradient produced a dramatic improvement
in purification. The batch adsorption step is very important
as enzymatic activity is lost and significantly less purification
is achieved when the material is adsorbed to the top of the
column. However, the most important information in this
figure is that the carboxylase activity in each fraction is










FIG. 3. Activity profile (Upper) and reducing SDS/PAGE anal-
ysis (10%1 silver-stained gel) of fractions from CM-Sepharose chro-
matography (Lower). The fraction numbers are on thex axis. A 7.5-1LI
sample from each fraction was analyzed by SDS/PAGE. The cpm,
shown on the y axis, represent the carboxylase activity in each lane.
The carboxylase activity was determined by the 14CO2 incorporation
into FLEEL in the standard assay. Lane L is loading material;
fractions 1-7 are flow-through; fractions 8-27 are wash; fractions
28-37 are elution. Molecular weights (x 10-3) are shown to the left.
corresponding SDS/PAGE analysis. Quantitation of the sil-
ver-stained gel by scanning reveals that the protein is 80-90%o
pure. The specific activity is 2 x 109 cpm per mg per hr.
Further evidence that the Mr 94,000 band represents the
carboxylase is presented in Fig. 4. A carboxylase preparation
purified by Affi-FIXQ/S and CM-Sepharose (lane 2) was
reapplied to the Affi-FIXQ/S column. Lane 3 shows that the
activity of carboxylase was removed when the Mr 94,000
protein bound to Affi-FIXQ/S. Lane 4 shows that the activity
again coeluted with the Mr 94,000 protein. This carboxylase
is from one of our earlier preparations and contained a
significant amount of inactive carboxylase. This explains the
observation that the amounts of protein in the Mr 94,000
bands in lanes 2 and 4 are approximately equal whereas the
activity is greater in the sample repurified by Affi-FIXQ/S;
only active carboxylase binds to the affinity column.
Purification of the Carboxylase. One of the problems with
using the affinity column is that the elution using the propep-
tide is very slow and requires several days to achieve an
adequate yield. We therefore explored alternative methods to
elute the enzyme from the affinity column. As shown in Fig.
5, we were able to remove essentially all contaminating
proteins without loss of carboxylase activity by washing the
loaded affinity column extensively with Triton X-100 fol-
lowed by a wash with CHAPS. The carboxylase could then
be eluted with a gradient of CHAPS in a high concentration
of NaCl (data not shown) or a gradient of CHAPS and
propeptide containing a high concentration of NaCl (Fig. 5).
The carboxylase activity coincides with the Mr 94,000 protein
profile. And, depending upon the fraction chosen, the car-
boxylase is 80-95% pure. If the propeptide is omitted from
the elution gradient, the carboxylase in higher concentrations
of CHAPS rapidly loses activity. Table 1 shows our final
purification scheme. Note that 30%o of the activity in the
starting material is bound (obtained by subtracting the activ-
ity in the flow-through from the load) and that 34% of total
activity is recovered by elution. Thus it appears that very
little of the observed increase in specific activity is due to the
removal of an inhibitor.
DISCUSSION
We have affinity-purified the carboxylase to 80-90% purity
with a yield of 34%. The procedure is rapid and efficient. The
entire purification can be accomplished in 4 days. It is
difficult to compare different purification schemes but, by
comparing final specific activities, it appears that our puri-




FIG. 4. Reducing SDS/PAGE analysis (silver-stained 10% gel) of
a CM-Sepharose-purified carboxylase rechromatographed on Affi-
FIXQ/S to show the correlation between the M, 94,000 protein and
activity. Lane 1 is the first Affi-FIXQ/S carboxylase preparation
(9750 cpm/30 min); lane 2 is purified CM-Sepharose eluate (6729
cpm/30 min, used for the second Affi-FIXQ/S); lane 3 is flow-
through of the second Affi-FIXQ/S (394 cpm/30 min); lane 4 is
sample of second Affi-FIXQ/S elute (18853 cpm/30 min, eluate I
method). The difference in activity between the carboxylase shown
in lanes 2 and 4 is the result of some inactivation of the carboxylase
of lane 2. Molecular weights (X10-3) are shown to the left.
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FIG. 5. Activity profile and reducing SDS/PAGE analysis (10%1 silver-stained gel) of fractions from Affi-FIXQ/S chromatography elution
II. A 5.0-1.l sample of each fraction was used for SDS/PAGE analysis except that the loading material and fraction 8 were diluted 1:100 before
analysis. The fraction number is shown on the x axis. The y axis represents the carboxylase activity in each lane. The carboxylase activity was
determined by the 14CO2 incorporation into FLEEL in the standard assay. Lane L is loading material; fractions 1-20 are flow-through (because
each fraction is equivalent, only one is shown); fractions 21-30 are wash; fractions 31-49 are Triton X-100 gradient; fractions 56-63 are CHAPS
gradient; fractions 64-75 are CHAPS/proFIX19 double gradient; fractions 76-90 are 1% CHAPS/2 AM proFIX19 elution. Molecular weights
(xlO-3) are shown on the right.
fication results in a carboxylase preparation that 185-fold
higher specific activity than the best previously published
method (11). From 14CO2 incorporation into the pentapeptide
FLEEL, we estimate the specific activity of our carboxylase
prepared by Affi-FIXQ/S chromatography eluted by method
II (Fig. 5) as 2.4 x 109 cpm per mg of protein per hr. This
represents a 7000-fold purification. Hubbard et al. (11) re-
ported a specific activity of 1.3 x 107 cpm per mg of protein
per hr with a 107-fold purification from their affinity purifi-
cation step. The results should be comparable, because the
CO2 used in the two experiments had the same specific
activities.
When the purified carboxylase is analyzed by nonreducing
SDS/PAGE, there is no evidence of a higher molecular
weight disulfide-bonded multimer. In nonreducing gels, how-
ever, there is a tight doublet of about Mr 94,000 that we
believe are conformers of the carboxylase. This suggestion is
supported by experiments (D.P.M., unpublished data) in
which limited tryptic digests of the Mr 94,000 protein yielded
only two polypeptides of approximately Mr 30,000 and Mr
64,000. This observation provides additional evidence that
there is only one Mr 94,000 protein in our preparation. It has
been reported that the carboxylase is inhibited by the sulf-
hydryl reagent p-hydroxymercuribenzoate (12), and Price
(18) has suggested that the carboxylase makes a disulfide
bond with its normal substrate. Thus alternative reduced
forms of the enzyme are not unexpected.
The major protein that coincides with the carboxylase
activity in our preparation has a Mr 94,000 in reducing
SDS/PAGE analysis. This is very different from the Mr
77,000 protein reported by Hubbard et al. (11). Flynn et al.
(19) demonstrated that many different small peptides could be
used for the single-step affinity purification of BiP (or glu-
cose-regulated protein, or hsp78) from solubilized mi-
crosomes. Hubbard et al. (11), using a similar starting ma-
terial and a similar purification scheme, obtained a protein
with the same molecular weight as BiP with a relatively low
specific activity for carboxylase. We concluded that the Mr
77,000 protein reported by Hubbard et al. (11) was BiP, one
of the most abundant proteins in the endoplasmic reticulum.
We tested BiP (obtained from Greg Flynn, Princeton Uni-
versity) for in vitro y-carboxylation and conclude that it does
not have carboxylase activity (data not shown). We have
observed no significant binding ofBiP to Affi-FIXQ/S. There
is also no evidence of a protein at Mr 77,000 in the elution
fractions 70-82 of Fig. 5 and FIXQ/S was not cross-linked to
a protein of this size. Furthermore, a monoclonal anti-BiP
antibody (obtained from David Bole, University of Michigan)
failed to detect BiP on a Western blot of our propeptide-
eluted carboxylase (60-fold purified; data not shown). Be-
cause of the amount of material loaded, we probably would
not have detected BiP if it were present at 1-2%. It is likely
that BiP tends to bind small peptides or that the peptide used
by Hubbard et al. (11) happened to have a strong affinity for
BiP. In addition to the Mr 78,000 glucose-regulated protein
BiP, there is a Mr 94,000 glucose-regulated protein (20) that
is present in relatively high concentrations and is, therefore,
a candidate for a contaminant in our preparation. However,
the amino acid sequence of five tryptic peptides of the
carboxylase clearly demonstrates that we have not purified
the Mr 94,000 glucose-regulated protein or, in fact, any other
known protein.
The method used in this paper for purification of the
carboxylase may have general importance for the purification
Table 1. Purification of carboxylase
Total
carboxylase
Total activity, Recovery of Specific activity,
Sample protein, mg cpm/30 min activity, % cpm per mg per hr Fold purification
Solubilized microsomes (load) 8100 1.14 x 109 100 2.81 x 105 1
Flow-through of Affi-FIXQ/S 8090 8.08 x 108 70 2 x 108 0.7
Bound to Affi-FIXQ/S 4.7 3.3 x 108 30 1.4 x 108 502
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of membrane proteins. A basic strategy for purifying integral
membrane proteins is to make micelles containing only one
protein. However, high concentrations of detergent often
result in the inactivation of the protein of interest. By
appropriate sonication, one can create smaller mixed mi-
celles without affecting the catalytic or binding ability of the
protein. Because the immobilized protein is often more
stable, the problems associated with mixed micelles can be
solved by carefully choosing the conditions for washing the
bound solid phase. This method ofwashing the bound protein
with a high concentration of detergent should also be appli-
cable to integral membrane proteins bound to standard ion-
exchange matrices.
Carboxylase is an integral membrane protein present in low
concentrations that has previously resisted purification. To
overcome the inherent difficulties, we chose affinity binding
as the first purification step. By manipulating the biophysical
properties of micelles, we were able to achieve a single-step
purification ofcarboxylase with 80-90% purity. Starting from
8 g ofmicrosomal protein, we can easily generate 300-400 ,ug
of carboxylase from a 25-ml Affi-FIXQ/S column, with a
final yield of 34% of the starting activity. Glycerol, which is
often used to stabilize the membrane protein during purifi-
cation, proved to be an important stabilizer for carboxylase.
It increases the thermal stability of carboxylase and also
increases the half-life of carboxylase at 40C. Although 20%o
glycerol does not inhibit carboxylase binding to Affi-
FIXQ/S, it does prevent carboxylase from being eluted by
proFIX19 and also inhibits the enzyme activity. The purified
carboxylase is very stable and can be stored at -700C for
months without loss of activity. This work provides the
necessary basis for genetic and mechanistic studies of this
important enzyme.
We thank Robert Bell (Duke University) and Harold Roberts
(University of North Carolina at Chapel Hill) for helpful discussions,
David Bole (University of Michigan) for a monoclonal antibody to
BiP, Greg Flynn (Princeton University) for a gift of BiP, Frank
Church (University ofNorth Carolina at Chapel Hill) for synthesizing
peptides, and Dan Frazier for preparing large quantities of mi-
crosomes. This work was supported by Grant HL06350-29 from the
National Institutes of Health.
1. Stenflo, J., Fernlund, P., Egan, W. & Roepstorff, P. (1974)
Proc. Natl. Acad. Sci. USA 71, 2730-2733.
2. Nelsestuen, G. L., Zytkovicz, T. H. & Howad, J. B. (1974) J.
Biol. Chem. 249, 6347-6350.
3. Magnusson, S., Sottrup-Jensen, L., Petersen, T. E., Morris,
H. R. & Dell, A. (1974) FEBS Lett. 44, 189-193.
4. Esmon, C. T., Sadowski, J. A. & Suttie, J. W. (1975) J. Biol.
Chem. 250, 4744-4748.
5. Pan, L. C. & Price, P. A. (1985) Proc. Natl. Acad. Sci. USA 82,
6109-6113.
6. Knobloch, J. E. & Suttie, J. W. (1987) J. Biol. Chem. 262,
16157-16163.
7. Jorgensen, M. J., Cantor, A. B., Furie, B. C., Brown, C. L.,
Shoemaker, C. B. & Furie, B. (1987) Cell 48, 185-191.
8. Girardot, J.-M. (1982) J. Biol. Chem. 257, 15008-15011.
9. Soute, B. A. M., Vermeer, C., de Metz, M., Hemker, H. C. &
Kijnen, H. R. (1981) Biochim. Biophys. Acta 676, 101-107.
10. Harbeck, M. C., Cheung, A. Y. & Suttie, J. W. (1989) Thromb.
Res. 56, 317-323.
11. Hubbard, B. R., Ulrich, M. M. W., Walsh, C., Furie, B. &
Furie, B. C. (1989) Proc. Natl. Acad. Sci. USA 86, 6893-6897.
12. Suttie, J. W. (1985) Annu. Rev. Biochem. 54, 459-477.
13. Wu, S.-M., Soute, B., Vermeer, C. & Stafford, D. W. (1990) J.
Biol. Chem. 265, 13124-13129.
14. Bradford, M. (1976) Anal. Biochem. 72, 248-254.
15. Laemmli, U. K. (1970) Nature (London) 227, 680-685.
16. Blum, H., Beier, H. & Gross, H. J. (1987) Electrophoresis 8,
93-99.
17. Jung, S. M. & Moroi, M. (1983) Biochim. Biophys. Acta 761,
152-162.
18. Price, P. A. (1988) Annu. Rev. Nutr. 8, 565-583.
19. Flynn, G. C., Chappell, T. G. & Rothman, J. E. (1989) Science
245, 385-390.
20. Mazzarella, R. A. & Green, M. (1987) J. Biol. Chem. 262,
8875-8883.
2240 Biochemistry: Wu et al.
